Latest Breaking News On - Nutrition annual meeting - Page 1 : comparemela.com

Ironwood Pharmaceuticals, Inc (NASDAQ:IRWD) Q3 2023 Earnings Call Transcript

Operator: Thank you for standing by. My name is Aaron, and I will be your conference operator for today.

United statesMatt rocheMike shetzlineMatt roacheSravan emanyJason butlerTom mccourtIronwood pharmaceuticalsAmerican society for pediatric gastroenterologyMost conservative companiesIronwood pharmaceuticals incCall transcript novemberUpdate conferenceRisk factorsChief executive officerChief medical officer

Ardelyx Reports Third Quarter 2023 Financial Results and Updates 2023 U S IBSRELA® Net Sales Revenue Guidance

Ardelyx Reports Third Quarter 2023 Financial Results and Updates 2023 U S IBSRELA® Net Sales Revenue Guidance
tmcnet.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from tmcnet.com Daily Mail and Mail on Sunday newspapers.

San diegoUnited statesHong kongBritish columbiaCaitlin lowieKimia keshtbodDarren brennerFosun pharmaDavid rosenbaumKimberley orleckKavita kongaraMike raabAnthony lemboExchange commission onKyowa kirin co ltdAmerican society for pediatric gastroenterology

Mirum Pharmaceuticals (MIRM) Presents Long-Term LIVMARLI Data and New Alagille Syndrome Caregiver Burden Analysis

Mirum Pharmaceuticals (MIRM) Presents Long-Term LIVMARLI Data and New Alagille Syndrome Caregiver Burden Analysis
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

United kingdomUnited statesWilliamf balistreriIan clementsBettina hansenBinitam kamathSam martinErin murphySaeed mohammadReginop gonzalez peraltaGlobal alagille allianceNational quantitative analysisDrug administrationStudy groupAmerican society for pediatric gastroenterologyEuropean medicines agency

Mirum Pharmaceuticals, Inc : Mirum Pharmaceuticals to Showcase LIVMARLI (maralixibat) Data at EASL and ESPGHAN Annual Congresses

Eight abstracts accepted, including three oral presentations Maralixibat data highlighting predictors of event-free survival in patients with Alagille syndrome nominated for prestigious Alex Mowat

United kingdomCity ofBinita kamathIan clementsBettina hansenRegino gonzalez peraltaRonald sokolSam martinErin murphyKathy loomesCory kostrubKris kowdleyMirum pharmaceuticalsDrug administrationEuropean medicines agencyMirum pharmaceuticals inc

Mirum Pharmaceuticals to Showcase LIVMARLI® (maralixibat) Data at EASL and ESPGHAN Annual Congresses

- Eight abstracts accepted, including three oral presentations - Maralixibat data highlighting predictors of event-free survival in patients with Alagille syndrome nominated for prestigious Alex. | June 13, 2022

United kingdomCity ofRonald sokolKathy loomesCory kostrubBinita kamathBettina hansenRegino gonzalez peraltaKris kowdleyMirum pharmaceuticalsDrug administrationEuropean medicines agencyMirum pharmaceuticals incEuropean society for paediatric gastroenterologyInternational liver congressEuropean association